Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma
REST regulates oncogenic properties of glioblastoma stem cells
REST Polyclonal Antibody (22242-1-AP)
Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma
RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma
Altered transcriptional regulatory proteins in glioblastoma and
LncRNA VIM-AS1 was overexpressed in glioma tissues. A, The correlation
Genes, Free Full-Text
Gene expression clustering and the separation between IDH-MUT and
Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma
The NRSF/REST transcription factor in hallmarks of cancer: From molecular mechanisms to clinical relevance - ScienceDirect
LncRNAs associated with glioblastoma: From transcriptional noise to novel regulators with a promising role in therapeutics - ScienceDirect
REST regulates oncogenic properties of glioblastoma stem cells
REST Polyclonal Antibody (22242-1-AP)
Comprehensive analysis of the transcription factor REST regulatory networks in IDH-mutant and IDH-wild type glioma cells and gliomas
